AMICUS THERAPEUTICS, INC.

FOLD

Form 4 • Statement of Changes in Beneficial Ownership

SEC Accession Number: 0001193125-26-092114
Filing date: Mar 4, 2026
Earliest execution date: Mar 2, 2026
Reporting Owners: Campbell Bradley L (CEO)

Summary

Type

Sell

Net shares

-22,500

% of shares

-2.20%

Amount (USD)

$322,839

Insider confidence score

41.3 out of 100

Positive

  • Under Rule 10b5-1 trading plan

Negative

  • Notable scheduled sell (<3% of shares)
  • Large sell amount ($250K+)

Stock transactions

Transaction 1

Security

Common Stock

Action

Sell

Date

2026-03-02

Code

S

Net shares

-22,500.0

Price per Share

$14.35

Amount (USD)

$322,839.00

Acquired/Disposed

Disposed

Shares Owned Before

1,021,180.0

Shares Owned After

998,680.0

Filing's footnotes

1. This price is the weighted average price for the transactions reported on this line. The prices for the transactions reported on this line range from $14.34 to $14.37 inclusive. The reporting person undertakes to provide, upon request, by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

ℹ️ Filed under Rule 10b5-1 trading plan

This page is for informational purposes only. While we strive for accuracy, the summary may contain inaccuracies or omissions. Please refer to the official SEC filing for authoritative information. Open the SEC filing.